Tajikistan Tech Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Tech Daily.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 10, 2025

November 10, 2025

Esperion Announces New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) in Oral and Poster Presentations at the AHA Scientific Sessions 2025

GlobeNewswire

November 10, 2025

BellSoft's Hardened Images Set New Standard for Container Security

GlobeNewswire

November 10, 2025

Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025

GlobeNewswire

November 10, 2025

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis

GlobeNewswire

November 10, 2025

Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference

GlobeNewswire

November 10, 2025

aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire

November 10, 2025

Senseonics Announces Transfer to Nasdaq Stock Exchange

GlobeNewswire

November 10, 2025

4DMT Reports Third Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

GlobeNewswire

November 10, 2025

SpyGlass Pharma Announces Positive 36-Month First-in-Human and 3-Month Phase I/II Trial Results for Its Novel BIM-IOL System

GlobeNewswire

November 10, 2025

Humacyte Announces Presentation of Positive Two-Year Results from Phase 3 Dialysis Access Trial at the American Society of Nephrology’s Kidney Week 2025

GlobeNewswire

November 10, 2025

Cognitive Training Found Most Effective Lifestyle Intervention to Prevent Cognitive Decline

GlobeNewswire

November 10, 2025

Parler Technologies to Host Live Webinar to Discuss Private Placement and its Fully Sovereign, End-to-End Technology Ecosystem

GlobeNewswire

November 10, 2025

Verrica Pharmaceuticals Presents New Data on VP-315 from its Phase 2 Clinical Trial in Basal Cell Carcinoma at the 40th Society for Immunotherapy of Cancer Annual Meeting

GlobeNewswire

November 10, 2025

Calidi Biotherapeutics Presents New Data on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting and Holds Its First Investor Day at SITC

GlobeNewswire

November 10, 2025

Acumen Pharmaceuticals Appoints George Golumbeski, Ph.D., as Chairman of its Board of Directors

GlobeNewswire

November 10, 2025

Madrigal Presents New Data Demonstrating Rezdiffra® (resmetirom) Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH Cirrhosis

GlobeNewswire

November 10, 2025

Jasper Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

November 10, 2025

Mersana Therapeutics to Host Third Quarter 2025 Conference Call on November 14, 2025

GlobeNewswire

November 10, 2025

XBP Global Schedules Conference Call for Third Quarter 2025 Financial Results

GlobeNewswire

November 10, 2025

Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market

GlobeNewswire